Brain Metastases

  • Carsten Nieder
  • Anca L. Grosu
  • Minesh P. Mehta
Part of the Medical Radiology book series (MEDRAD)


In many patients with brain metastases, the primary therapeutic aim is to accomplish symptom palliation and maintenance of neurologic function, but in a small selected cohort, long-term survival, and even cure, is possible. Central nervous system failures might develop after initial treatment, either locally (regrowth of a previously treated lesion), regionally (elsewhere, in the brain parenchyma), or even in the form of leptomeningeal dissemination, the latter carrying the worst prognosis. Some of these failures will not require local therapy because they develop in the terminal phase of general cancer progression, where active brain metastases treatment is neither expected to prolong survival nor improve the patient’s quality of life. At the other end of the spectrum, patients with limited brain-only relapse require effective intracranial disease control as a prerequisite for extended survival. This chapter reviews reirradiation with radioactive implants, stereotactic radiosurgery, fractionated stereotactic radiotherapy, and whole-brain radiotherapy and provides several illustrative examples.


Brain Metastasis Karnofsky Performance Status Radiation Therapy Oncology Group Recursive Partitioning Analysis Biologically Effective Dose 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Adler JR, Cox RS, Kaplan I, Martin DP (1992) Stereotactic radiosurgical treatment of brain metastases. J Neurosurg 76:444–449PubMedCrossRefGoogle Scholar
  2. Agboola O, Benoit B, Cross P et al (1998) Prognostic factors derived from recursive partitioning analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases. Int J Radiat Oncol Biol Phys 42:155–159PubMedCrossRefGoogle Scholar
  3. Ammirati M, Cobbs CS, Linskey ME et al (2010) The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:85–96PubMedCrossRefGoogle Scholar
  4. Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665–1672PubMedCrossRefGoogle Scholar
  5. Antoniou D, Kyprianou K, Stathopoulos GP et al (2005) Response to radiotherapy in brain metastases and survival of patients with non-small cell lung cancer. Oncol Rep 14:733–736PubMedGoogle Scholar
  6. Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radiosurgery alone for treatment of brain metastases. A randomized controlled trial. JAMA 295:2483–2491PubMedCrossRefGoogle Scholar
  7. Aoyama H, Tago M, Kato N et al (2007) Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68:1388–1395PubMedCrossRefGoogle Scholar
  8. Barajas RF, Chang JS, Sneed PK et al (2009) Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 30:367–372PubMedCrossRefGoogle Scholar
  9. Bernstein M, Cabantog A, Laperriere N et al (1995) Brachytherapy for recurrent single brain metastasis. Can J Neurol Sci 22:13–16PubMedGoogle Scholar
  10. Bhatnagar AK, Kondziolka D, Lunsford LD, Flickinger JC (2007) Recursive partitioning analysis of prognostic factors for patients with four or more intracranial metastases treated with radiosurgery. Technol Cancer Res Treat 6:153–160PubMedGoogle Scholar
  11. Borgelt B, Gelber R, Larson M et al (1980) The palliation of brain metastases: final results of the first two studies of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6:1–9PubMedCrossRefGoogle Scholar
  12. Borgelt B, Gelber R, Kramer S et al (1981) Ultra-rapid high dose irradiation scheduled for the palliation of brain metastases. Int J Radiat Oncol Biol Phys 7:1633–1638PubMedCrossRefGoogle Scholar
  13. Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037–1044PubMedCrossRefGoogle Scholar
  14. Chao ST, Barnett GH, Vogelbaum MA et al (2008) Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy. Cancer 113:2198–2204PubMedCrossRefGoogle Scholar
  15. Chatani M, Matayoshi Y, Masaki N, Inoue T (1994) Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase. Strahlenther Onkol 170:155–161PubMedGoogle Scholar
  16. Cho KH, Hall WA, Gerbi BJ et al (1998) Patient selection criteria for the treatment of brain metastases with stereotactic radiosurgery. J Neurooncol 40:73–86PubMedCrossRefGoogle Scholar
  17. Chung JK, Kim YK, Kim SK et al (2002) Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET. Eur J Nucl Med Mol Imaging 29:176–182PubMedCrossRefGoogle Scholar
  18. Cooper J, Steinfeld A, Lerch I (1990) Cerebral metastases: value of reirradiation in selected patients. Radiology 174:883–885PubMedGoogle Scholar
  19. Davey P, Schwartz ML, Scora D et al (2007) Fractionated (split dose) radiosurgery in patients with recurrent brain metastases: implications for survival. Br J Neurosurg 21:491–495PubMedCrossRefGoogle Scholar
  20. Dequesada IM, Quisling RG, Yachnis A, Friedman WA (2008) Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study. Neurosurgery 63:898–903PubMedCrossRefGoogle Scholar
  21. Engenhart R, Kimmig BN, Höver KH et al (1993) Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation. Cancer 71:1353–1361PubMedCrossRefGoogle Scholar
  22. Evans ES, Hahn CA, Kocak Z et al (2007) The role of functional imaging in the diagnosis and management of late normal tissue injury. Semin Radiat Oncol 17:72–80PubMedCrossRefGoogle Scholar
  23. Gaspar L, Scott C, Rotman M et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751PubMedCrossRefGoogle Scholar
  24. Gaspar LE, Mehta MP, Patchell RA et al (2010) The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96(1):17–32 Google Scholar
  25. Gelber RD, Larson M, Borgelt BB, Kramer S (1981) Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis. Cancer 48:1749–1753PubMedCrossRefGoogle Scholar
  26. Gonzalez J, Kumar AJ, Conrad CA, Levin VA (2007) Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 67:323–326PubMedCrossRefGoogle Scholar
  27. Gwak HS, Yoo HJ, Youn SM et al (2009) Radiosurgery for recurrent brain metastases after whole-brain radiotherapy: factors affecting radiation-induced neurological outcome. J Korean Neurosurg Soc 45:275–283PubMedCrossRefGoogle Scholar
  28. Hazuka MB, Kinzie JJ (1988) Brain metastases: results and effects of re-irradiation. Int J Radiat Oncol Biol Phys 15:433–437PubMedCrossRefGoogle Scholar
  29. Heflin LH, Meyerowitz BE, Hall P et al (2005) Cancer as a risk factor for long-term cognitive deficits and dementia. J Natl Cancer Inst 97:854–856PubMedCrossRefGoogle Scholar
  30. Huang K, Sneed PK, Kunwar S et al (2009) Surgical resection and permanent iodine-125 brachytherapy for brain metastases. J Neurooncol 91:83–93PubMedCrossRefGoogle Scholar
  31. Khuntia D, Brown P, Li J, Mehta MP (2006) Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 24:1295–1304PubMedCrossRefGoogle Scholar
  32. Klein M, Heimans JJ, Aaronson NK et al (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360:1361–1368PubMedCrossRefGoogle Scholar
  33. Kocher M, Voges J, Müller RP et al (1998) Linac radiosurgery for patients with a limited number of brain metastases. J Radiosurg 1:9–15CrossRefGoogle Scholar
  34. Kondziolka D, Patel A, Lunsford LD et al (1999) Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45:427–434PubMedCrossRefGoogle Scholar
  35. Kurup P, Reddy S, Hendrickson FR (1980) Results of re-irradiation for cerebral metastases. Cancer 46:2587–2589PubMedCrossRefGoogle Scholar
  36. Li J, Bentzen SM, Renschler M et al (2007) Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol 25:1260–1266PubMedCrossRefGoogle Scholar
  37. Loeffler JS, Kooy HM, Wen PY et al (1990) The treatment of recurrent brain metastases with stereotactic radiosurgery. J Clin Oncol 8:576–582PubMedGoogle Scholar
  38. Lorenzoni J, Devriendt D, Massager N et al (2004) Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys 60:218–224PubMedCrossRefGoogle Scholar
  39. Lutterbach J, Bartelt S, Stancu E, Guttenberger R (2002) Patients with brain metastases: hope for recursive partitioning analysis (RPA) class 3. Radiother Oncol 63:339–345PubMedCrossRefGoogle Scholar
  40. Nieder C, Berberich W, Schnabel K (1997) Tumor-related prognostic factors for remission of brain metastases after radiotherapy. Int J Radiat Oncol Biol Phys 39:25–30PubMedCrossRefGoogle Scholar
  41. Nieder C, Nestle U, Motaref B et al (2000) Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes? Int J Radiat Oncol Biol Phys 46:297–302PubMedCrossRefGoogle Scholar
  42. Nieder C, Geinitz H, Molls M (2008) Validation of the graded prognostic assessment index for surgically treated patients with brain metastases. Anticancer Res 28:3015–3017PubMedGoogle Scholar
  43. Nieder C, Marienhagen K, Geinitz H et al (2009) Validation of the graded prognostic assessment index for patients with brain metastases. Acta Oncol 48:457–459PubMedCrossRefGoogle Scholar
  44. Nieder C, Leicht A, Motaref B, Nestle U, Niewald M, Schnabel K (1999) Late radiation toxicity after whole brain radiotherapy: the influence of antiepileptic drugs. Am J Clin Oncol 22(6):573–579PubMedCrossRefGoogle Scholar
  45. Noël G, Proudhom MA, Valery CA et al (2001) Radiosurgery for reirradiation of brain metastases: results in 54 patients. Radiother Oncol 60:61–67PubMedCrossRefGoogle Scholar
  46. Ostertag CB, Kreth FW (1995) Interstitial iodine-125 radiosurgery for cerebral metastases. Br J Neurosurg 9:593–603PubMedCrossRefGoogle Scholar
  47. Patchell RA, Tibbs PA, Walsh JW et al (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494–500PubMedCrossRefGoogle Scholar
  48. Patchell RA, Tibbs PA, Regine WF et al (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280:1485–1489PubMedCrossRefGoogle Scholar
  49. Pirzkall A, Debus J, Lohr F et al (1998) Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 16:3563–3569PubMedGoogle Scholar
  50. Prados M, Leibel S, Barnett CM, Gutin P (1989) Interstitial brachytherapy for metastatic brain tumors. Cancer 63:657–660PubMedCrossRefGoogle Scholar
  51. Rades D, Pluemer A, Veninga T et al (2007a) A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Cancer 110:1551–1559PubMedCrossRefGoogle Scholar
  52. Rades D, Bohlen G, Pluemer A et al (2007b) Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Cancer 109:2515–2521PubMedCrossRefGoogle Scholar
  53. Rades D, Haatanen T, Schild SE, Dunst J (2007c) Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases. Cancer 110:1345–1350PubMedCrossRefGoogle Scholar
  54. Regine WF, Scott C, Murray K, Curran W (2001) Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04. Int J Radiat Oncol Biol Phys 51:711–717PubMedCrossRefGoogle Scholar
  55. Rugo HS, Ahles T (2003) The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research. Semin Oncol 30:749–762PubMedCrossRefGoogle Scholar
  56. Sadikov E, Bezjak A, Yi QL et al (2007) Value of whole brain re-irradiation for brain metastases—single centre experience. Clin Oncol (R Coll Radiol) 19:532–538CrossRefGoogle Scholar
  57. Serizawa T, Saeki N, Higuchi Y et al (2005) Diagnostic value of thallium-201 chloride single-photon emission computerized tomography in differentiating tumor recurrence from radiation injury after gamma knife surgery for metastatic brain tumors. J Neurosurg 102(Suppl):266–271PubMedCrossRefGoogle Scholar
  58. Shaw E, Scott C, Souhami L et al (1996) Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 34:647–654PubMedCrossRefGoogle Scholar
  59. Shaw E, Scott C, Souhami L et al (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47:291–298PubMedCrossRefGoogle Scholar
  60. Shehata WM, Hendrickson FR, Hindo WA (1974) Rapid fractionation technique and re-treatment of cerebral metastases by irradiation. Cancer 34:257–261PubMedCrossRefGoogle Scholar
  61. Sneed PK, Lamborn KR, Forstner JM et al (1999) Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 43:549–558PubMedCrossRefGoogle Scholar
  62. Sneed PK, Suh JH, Goetsch SJ et al (2002) A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53:519–526PubMedCrossRefGoogle Scholar
  63. Sperduto PW, Berkey B, Gaspar LE et al (2008a) A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70:510–514PubMedCrossRefGoogle Scholar
  64. Sperduto CM, Watanabe Y, Mullan J et al (2008b) A validation study of a new prognostic index for patients with brain metastases: the graded prognostic assessment. J Neurosurg 109(Suppl):87–89PubMedGoogle Scholar
  65. Sperduto PW, Chao ST, Sneed PK et al (2010) Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 77:655–661PubMedCrossRefGoogle Scholar
  66. Stea B, Suh JH, Boyd AP et al (2006) Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: determinants of response and its prognostic value for subsequent survival. Int J Radiat Oncol Biol Phys 64:1023–1030PubMedCrossRefGoogle Scholar
  67. Sterzing F, Welzel T, Sroka-Perez G et al (2009) Reirradiation of multiple brain metastases with helical tomotherapy. Strahlenther Onkol 185:89–93PubMedCrossRefGoogle Scholar
  68. Sundgren PC (2009) MR spectroscopy in radiation injury. AJNR Am J Neuroradiol 30:1469–1476PubMedCrossRefGoogle Scholar
  69. Sundstrom JT, Minn H, Lertola KK et al (1998) Prognosis of patients treated for intracranial metastases with whole-brain irradiation. Ann Med 30:296–299PubMedCrossRefGoogle Scholar
  70. Tendulkar RD, Liu SW, Barnett GH et al (2006) RPA classification has prognostic significance for surgically resected single brain metastasis. Int J Radiat Oncol Biol Phys 66:810–817PubMedCrossRefGoogle Scholar
  71. Terakawa Y, Tsuyuguchi N, Iwai Y et al (2008) Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med 49:694–699PubMedCrossRefGoogle Scholar
  72. Tokuuye K, Akine Y, Sumi M et al (1998) Reirradiation of brain and skull base tumors with fractionated stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 40:1151–1155PubMedCrossRefGoogle Scholar
  73. Torcuator R, Zuniga R, Mohan YS et al (2009) Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol 94:63–68PubMedCrossRefGoogle Scholar
  74. Varlotto JM, Flickinger JC, Niranjan A et al (2003) Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 57:452–464PubMedCrossRefGoogle Scholar
  75. Vogelbaum MA, Angelov L, Lee SY et al (2006) Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg 104:907–912PubMedCrossRefGoogle Scholar
  76. Weltman E, Salvajoli JV, Brandt RA et al (2001) Radiosurgery for brain metastases: who may not benefit? Int J Radiat Oncol Biol Phys 51:1320–1327PubMedCrossRefGoogle Scholar
  77. Wong WW, Schild SE, Sawyer TE, Shaw EG (1996) Analysis of outcome in patients reirradiated for brain metastases. Int J Radiat Oncol Biol Phys 34:585–590PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  • Carsten Nieder
    • 1
  • Anca L. Grosu
    • 2
  • Minesh P. Mehta
    • 3
  1. 1.Department of Oncology and Palliative MedicineNordland HospitalBodøNorway
  2. 2.Department of Radiation OncologyUniversity Hospital FreiburgFreiburgGermany
  3. 3.Department of Radiation OncologyThe Robert H. Lurie Comprehensive Cancer Center of Northwestern UniversityChicagoUSA

Personalised recommendations